Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Karen Salomon-Escoto

General Rheumatology · UMMHC

View

Dr. Jeffrey Sparks

General Rheumatology · PHS

View

Dr. Anisha Dua

Vasculitis · NU

View

Dr. Amanda Nelson

General Rheumatology · UNC

View

Dr. Alfred Kim

Lupus · WUSTL

View

Dr. Saira Sheikh

Lupus · UNC

View

Dr. Eleni Tiniakou

Myositis · UTHealth

View

Dr. Nilasha Ghosh

General Rheumatology · HSS

View

Dr. Simon Helfgott

General Rheumatology · BWH

View

Dr. Mike Putman

Vasculitis · Froedtert

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    STDr. Sara Tedeschi
    Leading Voice

    Dr. Sara Tedeschi

    Rheumatology · Crystal-Related Diseases
    Brigham and Women's Hospital
    saratedeschi

    Research

    Longitudinal Changes in Serum Urate Levels From Premenopause Through Postmenopause: Interrupted Time-Series Analyses

    2026

    Via Arthritis & Rheumatology

    Research

    Characterizing Adherence to a Mobile Health App for Patient-Reported Outcomes in Rheumatoid Arthritis

    2026

    Via Rheumatology and Therapy

    Research

    Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort study

    2026

    Via The Lancet. Rheumatology

    Research

    Longitudinal patterns of C-reactive protein values in calcium pyrophosphate deposition disease

    2026

    Via Scandinavian Journal of Rheumatology

    Research

    The OMERACT core domain sets for calcium pyrophosphate deposition disease

    2026

    Via Seminars in Arthritis and Rheumatism

    Research

    Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)

    2026

    Via Annals of the Rheumatic Diseases

    Research

    Treatment of Patients with CPPD Disease: Where Do We Begin and Where Are We Going?

    2026

    Via Arthritis & Rheumatology

    Research

    Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study

    2025

    Via Annals of the Rheumatic Diseases

    Research

    Systematic literature review on Calcium Pyrophosphate Deposition (CPPD) nomenclature: condition elements and clinical states—A G-CAN consensus project

    2025

    Via RMD Open

    Research

    Editorial: Calcium pyrophosphate deposition disease

    2025

    Via Frontiers in Medicine

    Research

    Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus

    2025

    Via Seminars in Arthritis and Rheumatism

    Research

    Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus

    2025

    Via Seminars in Arthritis and Rheumatism

    Research

    Coronary artery calcium and atherosclerotic cardiovascular disease risk scores in patients with calcium pyrophosphate deposition disease

    2025

    Via Rheumatology (Oxford, England)

    Research

    Pseudogout, chondrocalcinosis, CPPD et al: crystal clear… or clear as mud?—The time has come to reconsider the nomenclature of calcium pyrophosphate deposition

    2025

    Via Annals of the Rheumatic Diseases

    Research

    Genome-wide association study in chondrocalcinosis reveals ENPP1 as a candidate therapeutic target in calcium pyrophosphate deposition disease

    2025

    Via Annals of the Rheumatic Diseases